Blood Tests to Monitor Uveal Melanoma Patients for Liver Spread
Tests blood markers to detect early liver spread in adults with uveal melanoma.
Plain-language title generated from the registry record
Registry title: Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
Key facts
- Where
- Paris, FranceSee the site
Where in France
- Institut CurieParis, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut Curie
- Trial code
- NCT04424719
- Record updated
- 3 September 2025
- Original description
Biomarkers search for early diagnosis of liver metastases in patients with uveal melanoma who benefit from a follow-up tailored to their personalized risk of relapse.Read full original descriptionShow less
Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
Biomarkers search for early diagnosis of liver metastases in patients with uveal melanoma who benefit from a follow-up tailored to their personalized risk of relapse.
Inclusion: Patient aged of 18 years or more; Patient with uveal melanoma with high metastatic relapse risk defined as :; T2b/c/d ou ≥ T3,; or chromosom 3 or chromosom 8 abnormality by CGH array; Completion of treatment of the primary tumor ≤ 2 months; Patient able to comply with the schedule of visits and blood samples of the study; Signed informed consent form or legal representative.
Exclusion: Any social, medical or psychological condition making the research process impossible; Patient without french social insurance.